Teva to pay $225M to settle cholesterol drug price-fixing charges - Netscape Money & Business netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.
The U.S. branches of Teva and Glenmark will pay $225 million and $30 million, respectively, to settle what Politico notes are "long-running criminal price-fixing charges." Separately, Boehringer Ingelheim, a German drugmaker, is suing the U.S. government over its Medicare drug price negotiation effort.
Two major generic drug companies Monday settled charges of criminal price fixing with the Department of Justice (DOJ). The U.S. division of Israel-based Teva will pay a $225 million criminal penalty over five years, and the U.S. division of India-based Glenmark will pay a $30 million criminal penalty, the DOJ announced. The two companies entered…
Some consumer health advocates and pharmacists are concerned that the FDA and the FTC aren’t doing enough to monitor where more and more people see ads.